Global
Management
“A Historic Day, a Breakthrough Has Been Achieved”: China Eagerly Anticipates Changxin Memory’s IPO
Changxin Memory Technology (CXMT; hereinafter “Changxin Memory”), China’s largest DRAM manufacturer, has become the talk of the town after topping the market capitalization rankings on its first day o…
Management
Is the ‘Opening Rally’ Over?… China’s Blue-Chip Changxin Memory Slightly Down on Second Trading Day
Changxin Memory Technology (CXMT; hereinafter “Changxin Memory”), China’s largest DRAM manufacturer, is showing a slight decline on its second day of trading. Changxin Memory, which debuted on the Chi…
IT
Will Open Source Prevail?… The Route War in Silicon Valley Sparked by the Kimi K3
Chinese startup Moonshot AI has recently caused a stir in the U.S. artificial intelligence (AI) industry by fully releasing the weights of its self-developed AI model, “Kimi K3.” This is because the m…
Management
NVIDIA-Led 1,100 Trillion AI Deal... Bond Market Also Sounds Alarm Over 'Circular Financing'
Controversy over “circular financing” is reigniting amid a series of massive artificial intelligence (AI) investment and financial support deals recently finalized by NVIDIA. Warnings are growing that…
IT
Changxin Memory, Which Struggled with Losses Until the Year Before Last, Has Emerged as a Leading Stock in China [Cai Gong]
Changxin Memory Technology (CXMT; hereinafter “Changxin Memory”), China’s largest DRAM manufacturer, attracted significant attention as its stock price surged on its first day of trading on the Chines…
Stocks
As the AI-Driven Rally Slows Down… Global Capital Flows into Chinese Biotech
Global capital has recently been flowing into Chinese biotech companies. As the AI rally in global Shinhung stock markets has slowed, investors seeking high-growth alternatives are turning their atten…
Manufacturing
"Driven by PDRN, a New Growth Engine Derived from Ultra-Nano Probiotics, the Company Aims to Double Sales This Year and Return to Profit Next Year" [In-Depth Look at AccuGen ③]
AccuGen is accelerating its expansion into new bio-material businesses, including cosmetic and health functional food ingredients based on polydeoxyribonucleotide (PDRN) derived from lactic acid bacte…
Manufacturing
"Strengths in One-Stop Comprehensive Microbial Services, from AI Analysis to the Development, Production, and Delivery of Consumables" [In-Depth Look at AccuGen ②]
AccuGen is the only company in Korea to offer a one-stop comprehensive service that encompasses microbial analysis as well as the development, production, and delivery of consumables. AccuGen also hol…
Manufacturing
"Leaping from Genetic Testing and Medical Device Consumables to a Natural Microbial Materials Company" [In-Depth Look at AccuGen ①]
"We will transform AccuGen from a company specializing in genetic sample collection tubes and kits, as well as next-generation sequencing (NGS) microbiome testing, into a leading provider of natural m…
Manufacturing
"From Product Introduction to Joint Venture Establishment"... HANDOK Inc. Sees Full Effect of Its Dual-Pronged Strategy for Cancer and Rare Diseases
Mid-sized pharmaceutical company HANDOK Inc.(002390)is continuing its trend of improved performance, driven by its dual focus on anticancer drugs and treatments for rare diseases. HANDOK Inc. has trad…